An insight into the last 5-year patents on Porphyromonas gingivalis and Streptococcus mutans, the pivotal pathogens in the oral cavity

References

• Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015 Jan;15(1):30–44. doi: 10.1038/nri3785
   PubMed Web of Science ®Google Scholar
• Word Health Organization. Oral health. [cited 2023 Sep 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/oral-health
   Google Scholar
• Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018 Dec;16(12):745–759. doi: 10.1038/s41579-018-0089-x.
   PubMed Web of Science ®Google Scholar
• Segata N, Haake SK, Mannon P, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 2012 Jun 14;13(6):R42. doi: 10.1186/gb-2012-13-6-r42
   PubMed Web of Science ®Google Scholar
• Lu M, Xuan S, Wang Z. Oral microbiota: a new view of body health. Food Sci Hum Wellness. 2019 Mar 1;8(1):8–15. doi: 10.1016/j.fshw.2018.12.001
   Google Scholar
• Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010 Jul;8(7):481–490. doi: 10.1038/nrmicro2337
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012 Dec;27(6):409–419. doi: 10.1111/j.2041-1014.2012.00663.x.
   PubMed Web of Science ®Google Scholar
• Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. Isme J. 2013 May;7:(5):1016–1025. doi: 10.1038/ismej.2012.174
   PubMed Web of Science ®Google Scholar
• Wang T, Ishikawa T, Sasaki M, et al. Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: the central role of porphyromonas gingivalis. Front Med. 2022;9. doi: 10.3389/fmed.2022.822190
   Web of Science ®Google Scholar
• Gasmi Benahmed A, Kumar Mujawdiya P, Noor S, et al. Porphyromonas gingivalis in the development of periodontitis: impact on dysbiosis and inflammation. Arch Razi Inst. 2022 Oct 31;77(5):1539–1551. doi: 10.22092/ARI.2021.356596.1875
   PubMedGoogle Scholar
• Krzyściak W, Jurczak A, Kościelniak D, et al. The virulence of streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):499–515. doi: 10.1007/s10096-013-1993-7.
   PubMed Web of Science ®Google Scholar
• Busuioc M, Mackiewicz K, Buttaro BA, et al. Role of intracellular polysaccharide in persistence of streptococcus mutans. J Bacteriol. 2009 Dec;191(23):7315–7322. doi: 10.1128/JB.00425-09
   PubMed Web of Science ®Google Scholar
• Pathak JL, Yan Y, Zhang Q, et al. The role of oral microbiome in respiratory health and diseases. Respir med. 2021;185:106475. doi: 10.1016/j.rmed.2021.106475
   PubMed Web of Science ®Google Scholar
• Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022 Mar 2;14(1):1–11. doi: 10.1038/s41368-022-00163-7
   PubMed Web of Science ®Google Scholar
• Park SY, Hwang BO, Lim M, et al. Oral–gut microbiome axis in gastrointestinal disease and cancer. Cancers (Basel). 2021 Jan;13:(9):2124. doi: 10.3390/cancers13092124
   PubMed Web of Science ®Google Scholar
• Han YW. Oral bacteria as drivers for colorectal cancer. J Periodontol. 2014 Sep;85(9):1155–1157. doi: 10.1902/jop.2014.140039.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu Y, Zheng HJ, et al. The oral microbiota May have influence on oral cancer. Front Cell Infect Microbiol. 2019;9:476. doi: 10.3389/fcimb.2019.00476
   PubMed Web of Science ®Google Scholar
• Gnanasekaran J, Binder Gallimidi A, Saba E, et al. Intracellular porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers (Basel). 2020 Aug 18;12(8):2331. doi: 10.3390/cancers12082331
   PubMedGoogle Scholar
• Liu XB, Gao ZY, Sun CT, et al. The potential role of P.Gingivalis in gastrointestinal cancer: a mini review. Infect Agent Cancer. 2019 Sep 10;14(1):23. doi: 10.1186/s13027-019-0239-4
   PubMed Web of Science ®Google Scholar
• Yu L, Maishi N, Akahori E, et al. The oral bacterium streptococcus mutans promotes tumor metastasis by inducing vascular inflammation. Cancer Sci. 2022 Nov;113:(11):3980–3994.
   PubMed Web of Science ®Google Scholar
• Lafuente Ibáñez de Mendoza I, Maritxalar Mendia X, de la Fuente AMG, et al. Role of porphyromonas gingivalis in oral squamous cell carcinoma development: a systematic review. J Periodontal Res. 2020 Jan;55(1):13–22. doi: 10.1111/jre.12691
   PubMed Web of Science ®Google Scholar
• Kugaji MS, Kumbar VM, Peram MR, et al. Effect of resveratrol on biofilm formation and virulence factor gene expression of porphyromonas gingivalis in periodontal disease. APMIS Acta Pathol Microbiol Immunol Scand. 2019 Apr;127(4):187–195. doi: 10.1111/apm.12930
   PubMed Web of Science ®Google Scholar
• Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014:476068. doi: 10.1155/2014/476068
   PubMed Web of Science ®Google Scholar
• Clais S, Boulet G, Kerstens M, et al. Importance of biofilm formation and dipeptidyl peptidase IV for the pathogenicity of clinical porphyromonas gingivalis isolates. Pathog Dis. 2014 Apr;70:(3):408–413. doi: 10.1111/2049-632X.12156
   PubMed Web of Science ®Google Scholar
• Travis J, Banbula A, Potempa J. The role of bacterial and host proteinases in periodontal disease. Adv Exp Med Biol. 2000;477:455–465. doi: 10.1007/0-306-46826-3_46
   PubMed Web of Science ®Google Scholar
• Sheets SM, Potempa J, Travis J, et al. Gingipains from porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun. 2005 Mar;73(3):1543–1552. doi: 10.1128/IAI.73.3.1543-1552.2005.
   PubMed Web of Science ®Google Scholar
• Holt SC, Ebersole J, Felton J, et al. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science. 1988 Jan 1;239(4835):55–57. doi: 10.1126/science.3336774
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011 Nov 17;10(5):497–506. doi: 10.1016/j.chom.2011.10.006
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu S, Zhang S, et al. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA. J Periodontol. 2022 Apr;93:(4):515–525. doi: 10.1002/JPER.21-0144
   PubMed Web of Science ®Google Scholar
• Gualtero DF, Lafaurie GI, Buitrago DM, et al. Oral microbiome mediated inflammation, a potential inductor of vascular diseases: a comprehensive review. Front Cardiovasc Med. 2023;10:1250263. doi: 10.3389/fcvm.2023.1250263
   PubMed Web of Science ®Google Scholar
• Ryder MI. Porphyromonas gingivalis and Alzheimer disease: recent findings and potential therapies. J Periodontol. 2020 Oct;91(Suppl 1):S45–9. doi: 10.1002/JPER.20-0104
   PubMedGoogle Scholar
• de Molon RS, Rossa C Jr, Thurlings RM, et al. Linkage of periodontitis and rheumatoid arthritis: Current evidence and potential biological interactions. Int J Mol Sci. 2019 Jan;20(18):4541. doi: 10.3390/ijms20184541
   PubMed Web of Science ®Google Scholar
• Amissah F, Andey T, Ahlschwede KM. Nanotechnology-based therapies for the prevention and treatment of streptococcus mutans-derived dental caries. J Oral Biosci. 2021 Dec;63(4):327–336. doi: 10.1016/j.job.2021.09.002
   PubMed Web of Science ®Google Scholar
• Forssten SD, Björklund M, Ouwehand AC. Streptococcus mutans, caries and simulation models. Nutrients. 2010 Mar;2(3):290–298. doi: 10.3390/nu2030290
   PubMed Web of Science ®Google Scholar
• Marsh PD. Microbiology of dental plaque biofilms and their role in oral health and caries. Dent Clin North Am. 2010 Jul;54(3):441–454. doi: 10.1016/j.cden.2010.03.002
   PubMedGoogle Scholar
• Rosan B, Lamont RJ. Dental plaque formation. Microbes Infect. 2000 Nov;2(13):1599–1607. doi: 10.1016/S1286-4579(00)01316-2
   PubMed Web of Science ®Google Scholar
• Ajdić D, McShan WM, McLaughlin RE, et al. Genome sequence of streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434–14439. doi: 10.1073/pnas.172501299
   PubMed Web of Science ®Google Scholar
• Cui T, Luo W, Xu L, et al. Progress of antimicrobial discovery against the major cariogenic pathogen streptococcus mutans. Curr Issues Mol Biol. 2019;32:601–644. doi: 10.21775/cimb.032.601
   PubMed Web of Science ®Google Scholar
• Lemos JA, Palmer SR, Zeng L, et al. The biology of streptococcus mutans. Microbiol Spectr. 2019 Jan;7(1). doi: 10.1128/microbiolspec.GPP3-0051-2018
   PubMed Web of Science ®Google Scholar
• Bowen WH, Koo H. Biology of streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms. Caries Res. 2011;45(1):69–86. doi: 10.1159/000324598
   PubMed Web of Science ®Google Scholar
• Wen ZT, Yates D, Ahn SJ, et al. Biofilm formation and virulence expression by streptococcus mutans are altered when grown in dual-species model. BMC Microbiol. 2010 Apr 14;10(1):111. doi: 10.1186/1471-2180-10-111
   PubMedGoogle Scholar
• Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond). 2021 May 28;135(10):1233–1249. doi: 10.1042/CS20210040
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 2016 Jul 15;473(14):2023–2032. doi: 10.1042/BCJ20160115
   PubMed Web of Science ®Google Scholar
• Supuran CT. An overview of novel antimicrobial carbonic anhydrase inhibitors. Expert Opin Ther Targets. 2023 Jul-Dec;27(10):897–910. doi: 10.1080/14728222.2023.2263914
   PubMed Web of Science ®Google Scholar
• Nocentini A, Capasso C, Supuran CT. Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we Now? Antibiot (Basel). 2023Jan 10;12(1):142. doi: 10.3390/antibiotics12010142
   PubMed Web of Science ®Google Scholar
• D’Agostino I, Mathew GE, Angelini P, et al. Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors. J Enzyme Inhib Med Chem. 2022 Dec;37:(1):986–993. doi: 10.1080/14756366.2022.2055009
   PubMed Web of Science ®Google Scholar
• Plotniece A, Sobolev A, Supuran CT, et al. Selected strategies to fight pathogenic bacteria. J Enzyme Inhib Med Chem. 2023 Dec;38:(1):2155816. doi: 10.1080/14756366.2022.2155816
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. Carbonic anhydrase from porphyromonas gingivalis as a drug target. Pathogens. 2017Jul 15;6(3):30. doi: 10.3390/pathogens6030030
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett. 2013Jul 15;23(14):4067–4071. doi: 10.1016/j.bmcl.2013.05.063
   PubMed Web of Science ®Google Scholar
• Vullo D, Del Prete S, Osman SM, et al. Anion inhibition study of the β-class carbonic anhydrase (PgiCab) from the oral pathogen porphyromonas gingivalis. Bioorg Med Chem Lett. 2014Sep 15;24(18):4402–4406. doi: 10.1016/j.bmcl.2014.08.014
   PubMed Web of Science ®Google Scholar
• Dedeoglu N, De Luca V, Isik S, et al. Cloning, characterization and anion inhibition study of a β-class carbonic anhydrase from the caries producing pathogen streptococcus mutans. Bioorg Med Chem. 2015Jul 1;23(13):2995–3001. doi: 10.1016/j.bmc.2015.05.007
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the carbonic anhydrases from two pathogens of the oral cavity: streptococcus mutans and porphyromonas gingivalis. Curr Top Med Chem. 2016;16(21):2359–2368. doi:10.2174/1568026616666160413135522
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Bin Hafeez A, Jiang X, Bergen PJ, et al. Antimicrobial peptides: an update on classifications and databases. Int J Mol Sci. 2021 Oct 28;22(21):11691. doi: 10.3390/ijms222111691
   PubMed Web of Science ®Google Scholar
• Li S, Deng B, Li Z. Anti-streptococcus mutans polypeptide and application thereof. CN111378023A. 2020.
   Google Scholar
• Li Z, Liu Q, Deng B, et al. Polypeptide resistant to porphyromonas gingivalis and Fusobacterium nucleatum and application. CN110272472A. 2019.
   Google Scholar
• Li Z, Liu Q, Deng B, et al. Antimicrobial peptide and application thereof. CN110305194A. 2019.
   Google Scholar
• Li Z, Liu Q, Deng B, et al. Polypeptide resistant to oral pathogens and application. CN110317247A. 2019.
   Google Scholar
• Li Z, Liu Q, Deng B, et al. Anti-porphyromonas gingivalis polypeptide and application thereof. CN110305193A. 2019.
   Google Scholar
• Jin Y, Wang F, Yang J. Antibacterial peptide MAMP-01 and application thereof. CN114149486A. 2022.
   Google Scholar
• Wang F, Jin Y, Yang J. Antibacterial peptide MAMP-03 and application thereof. CN114149484A. 2022.
   Google Scholar
• Jin Y, Wang F, Yang J. Antibacterial peptide composition and application thereof. CN114149483A. 2022.
   Google Scholar
• Tu H, Qiu L, Zhang X, et al. Streptococcus mutans specific targeting antibacterial peptide and application thereof. CN112961216A. 2021.
   Google Scholar
• Zhang Y, Manchu R, Wei H, et al. Combined antibacterial peptide with antibacterial activity on streptococcus mutans and application thereof. CN114106102A. 2022.
   Google Scholar
• Dongru C, Huancai L, Yucong C, et al. Aggregating polypeptide and its application. CN116462741A. 2023.
   Google Scholar
• Shah IM, German J, Mills D, et al. Peptides from human B-Casein that have anti-bacterial activity. WO2022103854A3. 2022
   Google Scholar
• Pasero C, D’Agostino I, De Luca F, et al. Alkyl-guanidine compounds as potent broad-spectrum antibacterial agents: chemical library extension and biological characterization. J Med Chem. 2018Oct 25;61(20):9162–9176. doi: 10.1021/acs.jmedchem.8b00619
   PubMed Web of Science ®Google Scholar
• Cole ST. Who will develop new antibacterial agents? Philos Trans R Soc B Biol Sci. 1645 [2014 Jun 19];369(1645):20130430. doi: 10.1098/rstb.2013.0430
   Google Scholar
• Barrett AJ. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J. 1980 Jun 1;187(3):909–912. doi: 10.1042/bj1870909
   PubMed Web of Science ®Google Scholar
• Lynch CC, Konradi A, Galemmo J, Aminopyridine compounds and methods for the preparation and use thereof. WO2018209132A1. 2018
   Google Scholar
• Galemmo JA, Konradi AW, Lynch CC, et al. Arginine gingipain inhibitors. WO2020191348A1. 2020.
   Google Scholar
• Marzolini C, Mueller R, Li-Blatter X, et al. The brain entry of HIV-1 protease inhibitors is facilitated when used in combination. Mol Pharm. 2013 Jun 3;10(6):2340–2349. doi: 10.1021/mp300712a
   PubMedGoogle Scholar
• Booth V, Ashley FP, Lehner T. Passive immunization with monoclonal antibodies against porphyromonas gingivalis in patients with periodontitis. Infect Immun. 1996 Feb;64(2):422–427. doi: 10.1128/iai.64.2.422-427.1996
   PubMed Web of Science ®Google Scholar
• Konradi AW, Galemmo R, Dominy SS, et al., Ketone inhibitors of Lysine Gingipain. WO2018053353A1. 2018
   Google Scholar
• Konradi AW, a GJ, Dominy SS, et al., Ketone inhibitors of Lysine Gingipain. US2023142714A1. 2023
   Google Scholar
• Kawaguchi S, Agent for prevention and/or treatment of porphyromonas gingivalis infection. WO2023026957A1. 2023
   Google Scholar
• Macia E, Ehrlich M, Massol R, et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006 Jun;10(6):839–850. doi: 10.1016/j.devcel.2006.04.002
   PubMed Web of Science ®Google Scholar
• Chen CH, Xie H, Inhibitors of intracellular invasion. WO2018035497A1. 2018
   Google Scholar
• Velu SE, Wu H, Zhang Q, et al. Streptococcus mutans glucosyl transferase inhibitors for dental caries therapy. WO2019195430A1. 2019.
   Google Scholar
• Naidoo R, Patel M, Gulube Z, et al. Inhibitory activity of Dodonaea viscosa var. angustifolia extract against streptococcus mutans and its biofilm. J Ethnopharmacol. 2012 Oct 31;144(1):171–174. doi: 10.1016/j.jep.2012.08.045
   PubMed Web of Science ®Google Scholar
• Michalek SM, McGhee JR, Shiota T, et al. Virulence of streptococcus mutans: cariogenicity of S. mutans in adult gnotobiotic rats. Infect Immun. 1977;15(2):466–471. doi: 10.1128/iai.15.2.466-471.1977
   PubMed Web of Science ®Google Scholar
• Yan L, Zhou X, Pang S. Application of ellagic acid in preparation of medicines for inhibiting pathogenicity of streptococcus mutans. CN109674783A. 2019.
   Google Scholar
• Bo T, Yang L, Jiaman L, et al. Sargassum fusiforme polyphenol with streptococcus mutans inhibition capability and. CN111807939A. 2020.
   Google Scholar
• Li Y, Shui Y. Application of houttuyfonate analogue in preparation of streptococcus mutans growth and biofilm inhibitor. CN113143904A. 2021.
   Google Scholar
• Yang L, Schoenfisch MH. Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto. ACS Appl Bio Mater. 2018;1(4):1066–1073. doi: 10.1021/acsabm.8b00304
   PubMedGoogle Scholar
• Schoenfisch MH, Yang L, Jin H. Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto. WO2019099525A1. 2019.
   Google Scholar
• Mullish BH, Allegretti JR. The contribution of bile acid metabolism to the pathogenesis of clostridioides difficile infection. Ther Adv Gastroenterol. 2021;14:17562848211017725. doi: 10.1177/17562848211017725
   Web of Science ®Google Scholar
• Sato Y, Atarashi K, Plichta DR, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021 Nov;599:(7885):458–464.
   PubMed Web of Science ®Google Scholar
• Lei Z, Fan Z, Kun S, et al. Bile acid-metronidazole conjugate and application thereof. CN115785185A. 2023.
   Google Scholar
• Yoshikawa K, Nakayama Y, Hayashi M, Unemoto T, Korormicin MK. An antibiotic specific for gram-negative marine bacteria, strongly inhibits the respiratory chain-linked Na±translocating NADH: quinone reductase from the marine vibrio alginolyticus. J Antibiot (Tokyo). 1999 Feb;52(2):182–185. doi: 10.7164/antibiotics.52.182
   PubMed Web of Science ®Google Scholar
• Dibrov P, Dibrov E, Pierce G, Derivatives of korormicin useful as antibiotics. WO2016168938A1. 2016
   Google Scholar
• Sung KH, Mi YK, Hak BK, et al. Derivative of a hydroxy-substituted c15-20 fatty acid and composition for prevention or treatment of oral disease comprising the same as an active ingredient. KR20210156791A. 2021.
   Google Scholar
• Kim KY, Kim HW, Lee TH, et al. Naphthoquinone derivatives compound and a composition containing the same for antibacterial activity. KR20220007439A. 2022.
   Google Scholar
• Koch C, Nordzieke S, A method for fighting microorganisms using menthol derivatives. WO2022122144A1. 2022
   Google Scholar
• Song Z, Zhou W, Zhou L, et al. Application of glaucocalyxin a in preparation of product for preventing and treating periodontal disease. CN111840263A. 2020.
   Google Scholar
• Li Y, Lei Z, Qiu Y, et al. Application of nicotinamide in preparation of medicine for resisting porphyromonas gingivalis. CN113908157A. 2022.
   Google Scholar
• Li Y, Lin Y, Lei Z, et al. Application of nicotinamide in preparation of inhibitor for streptococcus mutans acid production and biofilm formation. CN113197897A. 2021.
   Google Scholar
• Ksiazek M, Mizgalska D, Enghild JJ, et al. Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop. J Biol Chem. 2015 Jan 2;290(1):658–670. doi: 10.1074/jbc.M114.601716
   PubMed Web of Science ®Google Scholar
• Potempa JS, Ksiazek M, Mizgalska DM, et al. Recombinant Miropin. WO2022226451A1. 2022
   Google Scholar
• Chen Y, Liu N, Miao D, et al. Application of MicrocinC7 in preparation of periodontal disease treatment medicine. CN115581759A. 2023.
   Google Scholar
• Arnaboldi PM, Narasimhan S. Hygromycin a in the Lymelight. Cell Host Microbe. 2021 Nov 10;29(11):1599–1601. doi: 10.1016/j.chom.2021.10.007
   PubMed Web of Science ®Google Scholar
• Tindall M, Lewis K. Hygromycin a for treatment of diseases and infections. WO2023049849A1. 2023.
   Google Scholar
• Qingfan L, Haiying C, Longfeng W. Application of gentian in treating chronic periodontitis and gentian alcohol extract. CN116251131A. 2023.
   Google Scholar
• Bae JM, Kim SH. Compositions for preventing or treating oral disease or bone disease comprising extracts of brachypodium sylvaticum. KR102061981B1. 2020.
   Google Scholar
• Bae JM, Kim SH. Compositions for preventing or treating oral disease or bone disease comprising extracts of Colocasia antiquorum var. Exculenta. KR20200034451A. 2020.
   Google Scholar
• Bae JM, Kim SH. Compositions for preventing or treating oral disease or bone disease comprising extracts of Asplenium incisum. KR20200034452A. 2020.
   Google Scholar
• Kim SH. Compositions for preventing or treating oral disease or bone disease comprising extracts of sagittaria genus. KR20210065721A. 2021.
   Google Scholar
• Geng C, Chen J, Yan M, et al. Applications of Broussonetia papyrifera extract in preparation of products for oral diseases. CN108904594A. 2018.
   Google Scholar
• Geng C, Chen J, Yan M, et al. Application of flavonoids from Broussonetia papyrifera in the preparation of anti-oral bacterial drugs. CN109172640A. 2019.
   Google Scholar
• Lim ST. Antibacterial composition for porphyromonas gingivalis comprising plant extract or lactic acid bacteria fermentation product thereof. KR20200017912A. 2020.
   Google Scholar
• Wang X, Liu P. Application of frankincense extract in oral antibacterial composition. CN110368335A. 2019.
   Google Scholar
• Jin T, Naito M. Compositions and methods for inhibiting growth of caries-, Gingivitis- and halitosis-causing bacteria. US2020289391A1. 2020.
   Google Scholar
• Shin KH. Composition for oral cavity containing herbal extracts. KR20220019489A. 2022.
   Google Scholar
• Cho CS. Compositions for preventing improving or treating periodontal disease containing Dendropanax Morbifera Lev. Extracts KR20220110931A. 2022.
   Google Scholar
• Nam SH. Antibacterial composition for porphyromonas gingivalis containing extract of the Clematis Florida Thunb as an active ingredient. KR20230035872A. 2023.
   Google Scholar
• Hee NS. Antibacterial composition comprising cibotium barometz J. Smith extract as an active ingredient. KR20230056190A. 2023.
   Google Scholar
• Cho CS. Compositions for preventing improving or treating periodontal disease containing lagerstroemia speciosa leaf extracts. KR20220111022A. 2022.
   Google Scholar
• Tani H, Yamaki A, Yamaya M. Method for suppressing antibacterial activity of honey, and method for producing antibacterial agent. JP2021187840A. 2021.
   Google Scholar
• Li L, Gao Y, Kong X, et al. Composition for repairing oral cavity, gel preparation prepared from composition and application of gel preparation. CN115154501A. 2022.
   Google Scholar
• Hui YN, Min KY, Shuk SK, et al. Composition for preventing, ameliorating or treating periodontal disease comprising persimmon calyx extract as effective component. KR20230000985A. 2023.
   Google Scholar
• Yoshino N, Ikeda T, Nakao R. Fungicide for porphyromonas gingivalis, and method for producing component having antifungal action against porphyromonas gingivalis. JP2022154653A. 2022.
   Google Scholar
• Deung PH, Ji CE, Shin KH. Composition for inhibition of biofilm formation by streptococcus mutants comprising effective amount of rafinose. KR20180006800A. 2018.
   Google Scholar
• Weng SL, Qiu QX, Zhou CZ, et al. Method for preparing seaweed extract and product application thereof capable of inhibiting growth of streptococcus mutans for oral care. TW202045133A. 2020.
   Google Scholar
• Her Y, Oh JH. Ginsenosides and their crude extracts which have antibacterial activity against streptococcus mutans. KR20200019358A. 2020.
   Google Scholar
• Kim YJ, Han HS, Lee KD. Anti-bacterial composition for streptococcus mutans and composition for removing halitosis using the same. KR20210012529A. 2021.
   Google Scholar
• Vitale I, Spano M, Puca V, et al. Antibiofilm activity and NMR-based metabolomic characterization of cell-free supernatant of Limosilactobacillus reuteri DSM 17938. Front Microbiol. 2023;14:1128275. doi: 10.3389/fmicb.2023.1128275
   PubMed Web of Science ®Google Scholar
• Maccelli A, Carradori S, Puca V, et al. Correlation between the antimicrobial activity and metabolic profiles of cell free supernatants and membrane vesicles produced by lactobacillus reuteri DSM 17938. Microorganisms. 2020 Oct 24;8(11):1653. doi: 10.3390/microorganisms8111653
   PubMed Web of Science ®Google Scholar
• Seminario-Amez M, López-López J, Estrugo-Devesa A, et al. Probiotics and oral health: a systematic review. Med Oral Patol Oral Cir Bucal. 2017 May;22(3):e282. doi: 10.4317/medoral.21494
   PubMed Web of Science ®Google Scholar
• Paek NS, Kang CH. Lactobacillus salivarius having anticariogenic activities and composition comprising the same. KR20200070081A. 2020.
   Google Scholar
• Yu X, Yu Y, Ma X, Application of lactobacillus salivarius in protecting oral health. AU2021106148A4. 2021
   Google Scholar
• Liu H, Tao H, Luo Y, et al. Lactobacillus salivarius strain ZK-88 for inhibiting inflammation, relieving swelling and aching of gum and improving oral flora balance. CN114164157A. 2022.
   Google Scholar
• Duan Z, Zhang J, Guo C, et al. Saliva combined lactobacillus with effects of preventing or treating decayed teeth and periodontal diseases. CN115960741A. 2023.
   Google Scholar
• Ellepola K, Liu Y, Cao T, et al. Bacterial GtfB augments Candida albicans accumulation in Cross-Kingdom biofilms. J Dent Res. 2017 Sep;96(10):1129–1135. doi: 10.1177/0022034517714414
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang Q, Qin S, et al. Method capable of inhibiting streptococcus mutans and candida albicans double-bacteria biofilm. CN109908185A. 2019.
   Google Scholar
• Xu Z, Cheng L, Gao L, et al. Composition for inhibiting streptococcus mutans and application of composition. CN111588838A. 2020.
   Google Scholar
• Zhang H, Xie Y, Qiao R, et al. Lactobacillus plantarum SD26 as well as product and application thereof. CN112175884A. 2021.
   Google Scholar
• Zheng Y, Hu M, Zhang Q, et al. Lactobacillus plantarum for preventing and/or treating periodontitis as well as culture, preparation and application of lactobacillus plantarum. CN113005055A. 2021.
   Google Scholar
• Duan Z, Zhang J, Cheng S, et al. Phytobacterium plantarum and application thereof in prevention or treatment of oral diseases. CN115960740A. 2023.
   Google Scholar
• Ho HH, Lin WY, Kuo YW, et al. Composition for improving oral immunoglobulin a content and inhibiting pathogens, and use. WO2022180587A1. 2022.
   Google Scholar
• He X, Lin W, Guo Y, et al. Composition for increasing content of oral immunoglobulin a and inhibiting pathogenic bacteria and application thereof. CN114948843A. 2022.
   Google Scholar
• Ni H, Danji Zhang J, Liu J, et al. Phytobacterium plantarum with effects of preventing or treating decayed teeth and periodontal diseases and application of phytobacterium plantarum. CN115820450A. 2023.
   Google Scholar
• Fang S, Zuo H, Zhu M, et al. Lactobacillus plantarum strain WKA86, application of lactobacillus plantarum strain WKA86 in preparation of product for preventing and treating ozostomia and product. CN114574405A. 2022.
   Google Scholar
• Kang SS, Kim MY, Hyunin K. Use of lactobacillus plantarum and lactobacillus rhamnosus in the prevention amelioration or treatment of periodontal disease. KR20230105718A. 2023.
   Google Scholar
• Zhang Q, Chen W, Xu W, et al. Lactobacillus rhamnosus capable of preventing and/or treating periodontitis and application thereof. CN113046258A. 2021.
   Google Scholar
• Zhang J, Duan Z, Wu S, et al. Lactobacillus rhamnosus and application thereof in prevention or treatment of decayed teeth and periodontal diseases. CN115960739A. 2023.
   Google Scholar
• Qi MS, Liu X, Guo X. Application of lactobacillus rhamnosus R7970 in preparation of pathogenic bacterium inhibition product. CN115317522A. 2022.
   Google Scholar
• Fang S, Kong S, Zhu M, et al. Application of lactobacillus rhamnosus strain LRa05 in preparation of product for inhibiting helicobacter pylori and/or streptococcus mutans. CN115153026A. 2022.
   Google Scholar
• Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967 Nov;38(6):610–616.
   Web of Science ®Google Scholar
• Paek NS, Kang CH. MG505 lactobacillus reuteri MG505 having anticariogenic activities and composition comprising the same. KR20200070080A. 2020.
   Google Scholar
• Huazhu L. Composite probiotic composition for oral cavity, application and product thereof. CN116492285A. 2023.
   Google Scholar
• Li X, Zhang G, Zhao Y, et al. Probiotic composition for inhibiting streptococcus mutans and application of probiotic composition. CN113273697A. 2021.
   Google Scholar
• Liu X, Gao Y, Ma J, et al. Lactobacillus paracasei probio-01 and application of lactobacillus paracasei probio-01 in preparation of probiotic oral preparation. CN114606164A. 2022.
   Google Scholar
• Paek NS, Kang CH. Probiotics for prevention or treatment of periodontitis and use thereof. KR102217525B9. 2021.
   Google Scholar
• Zhang J, Liu J, Ni H, et al. Lactobacillus paracasei and application thereof in prevention or treatment of oral diseases. CN115717113A. 2023.
   Google Scholar
• Zhang L, Ma C, Ma J, et al. Isolated lactobacillus paracasei PC-01 for promoting oral health and application of lactobacillus paracasei PC-01. CN110257297A. 2019.
   Google Scholar
• Kim TH, Ryu DW, Choi WJ. Lacticaseibacillus paracasei strain for suppressing periodontal disease inducing bacteria and use thereof. KR102491641B1. 2023.
   Google Scholar
• Qiang F, Mengfan Z, Xiumei Z. Herbal mouthwash containing lactobacillus sanfranciscensis and preparation method thereof. CN116327675A. 2023.
   Google Scholar
• Hu L, Cornacchione L. Strains of Lactobacillus Delbrueckii which inhibit porphyromonas gingivalis. WO2020191111A1. 2020.
   Google Scholar
• Park JS, Lee DJ, Lee DS. Novel Lactobacillus acidophilus strain having streptococcus mutans inhibition and anti-inflammatory effect and use thereof. KR20220170630A. 2022.
   Google Scholar
• Jin T, Naito M, Probiotic for oral health. WO2022016266A1. 2022
   Google Scholar
• Cui A. Streptococcus thermophilus strain P0012, oral health care probiotic composition prepared from streptococcus thermophilus strain P0012 and application of streptococcus thermophilus strain P0012. CN116024128A. 2023.
   Google Scholar
• Zhong Z, Liu W, Guo L, et al. New streptococcus and application of streptococcus preparation to inhibition of oral pathogens. CN111471628A. 2020.
   Google Scholar
• Liu H, Tao H, Luo Y, et al. Bifidobacterium animalis strain ZK-77 for inhibiting pathogenic bacteria, relieving inflammation and regulating flora balance. CN114164158A. 2022.
   Google Scholar
• Li C, Luan C, Zhao Y, et al. Leuconostoc mesenteroides and application of leuconostoc mesenteroides in preparation of oral care products, health care products, medicines or foods for inhibiting porphyromonas gingivalis. CN114621898A. 2022.
   Google Scholar
• Wang Z, Zhang D, Li M, et al. A strain of Weizmannia coagulans GBW0011 and its application in the preparation of oral bacteriostatic agents. CN116355788A. 2023.
   Google Scholar
• Yalin L. Oral care solution containing probiotics. CN114432227A. 2022.
   Google Scholar
• Ding Y, Song S, Dai J, et al. Bacillus coagulans for high-efficiency antagonism of streptococcus mutans, preparation method of bacterial powder, chewing gum containing bacterial powder and application. CN110195029A. 2019.
   Google Scholar
• Nussbaum G, Kirshning C. Bacteria expressing single chain antibodies against toll-like receptors. WO2020075171A1. 2020.
   Google Scholar
• Burns E, Bachrach G, Shapira L, et al. Cutting edge: TLR2 is required for the innate response to porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol. 2006 Dec 15;177(12):8296–8300.
   PubMed Web of Science ®Google Scholar
• Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods. 2013 Aug 30;394(1–2):49–54. doi: 10.1016/j.jim.2013.05.002
   PubMed Web of Science ®Google Scholar
• Pang Y, Wu B, Wei Y. Yolk antibody composition to prevent and treat pathogenesis of Helicobacter pylori, porphyromonas gingivalis and streptococcus mutans, product prepared with yolk antibody composition and application of yolk antibody composition. CN109908346A. 2019.
   Google Scholar
• Xu Y, Liu X, Gui S, et al. Specific anti-porphyromonas gingivalis egg yolk antibody liposome solution and preparation method thereof. CN112274638A. 2021.
   Google Scholar
• Sadri L, Tavakoli R, Akbari MS, et al., Anti-streptococcus mutans and streptococcus subrinus immunoglobulins powder of egg yolk. WO2022144580A1. 2022
   Google Scholar
• Hu Y, Li H, Li J, et al. Application of antibody-bacteriolysin (SM-ScFv-fc-ly) in treatment of streptococcus mutans infection. CN115232207A. 2022.
   Google Scholar
• Heggers JP, Kucukcelebi A, Stabenau CJ, et al. Wound healing effects of aloe gel and other topical antibacterial agents on rat skin. Phytother Res. 1995;9(6):455–457. doi: 10.1002/ptr.2650090615
   Web of Science ®Google Scholar
• Hutter JA, Salman M, Stavinoha WB, et al. Antiinflammatory C-glucosyl chromone from Aloe barbadensis. J Nat Prod. 1996 May;59:(5):541–3. doi: 10.1021/np9601519
   PubMed Web of Science ®Google Scholar
• Im SA, Oh ST, Song S, et al. Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. Int Immunopharmacol. 2005 Feb 1;5(2):271–279. doi: 10.1016/j.intimp.2004.09.031
   PubMed Web of Science ®Google Scholar
• Mehrani SJ, Gill P. Fabrication of aloe vera nano-cellulose via mechanical method. WO2018104971A1. 2018.
   Google Scholar
• Fu Q. Bioactive borate glasses. WO2020106514A1. 2020.
   Google Scholar
• Fu Q. Bioactive silicate glasses. WO2020112404A1. 2020.
   Google Scholar
• Shi X. Cra4s1 gene, encoded Cra4s1 protein, and application. WO2021017365A1. 2021.
   Google Scholar
• Daniela CDMA, Fernanda PDS, João CPDM, et al. Use of microstructured polymer with Limonium brasiliense and respective microparticles. BR102020023491A2. 2022.
   Google Scholar
• Zhang HG. Plant-derived exosome-like nanoparticles inhibit bacterial pathogenicity. WO2020180801A1. 2020.
   Google Scholar
• Nara PL, Sindelar DL, Antigen-binding molecules that bind to Porphyromonas gingivalis. WO2022098661A1. 2022
   Google Scholar
• Kutschera GM, Mang TS, Photodynamic therapy compositions and methods of use thereof. WO2022056299A1. 2022
   Google Scholar
• Reynolds EC, Slakeski N. Chimeric polypeptides. WO2023137519A1. 2023.
   Google Scholar
• Sun X, Lin T, Chen S, et al. Application of OTUD6A protein in preparation of medicine for preventing or treating periodontitis. CN116042815A. 2023.
   Google Scholar
• Wu PC, Shieh DB, Cheng FY, et al. Methods for treating periodontal diseases. US2020172961A1. 2020.
   Google Scholar
• Liu C, Chen R, Du M. An immunoliposome drug targeting Porphyromonas gingivalis and its preparation method and application. CN116392444A. 2023.
   Google Scholar
• Liu CI, Lin YS, Su HJ, et al. Composition for inhibition of Streptococcus mutans. TW202247840A. 2022.
   Google Scholar
• Yang Y, Li Q, Yang D. Cascade nano-enzyme for targeted photocatalysis of Streptococcus mutans biological membrane. CN115671264A. 2023.
   Google Scholar
• Singh SB, Young K, Silver LL. What is an “ideal” antibiotic? Discovery challenges and path forward. Biochem Pharmacol. 2017 Jun 1;133:63–73. doi: 10.1016/j.bcp.2017.01.003
   PubMed Web of Science ®Google Scholar
• Schofield C. Antibiotics: current innovations and future trends. Norfolk (UK): Caister Academic Press; Sánchez, Sergio, Demain, Arnold L, 2015. p. 430.
   Google Scholar